Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Scleroderma Patient-centered Intervention Network (SPIN) - Scleroderma Support Group Leader EDucation (SSLED) Program Feasibility Trial

NCT03508661 is registered in ClinicalTrials.gov with Lady Davis Institute as lead sponsor.

NCT NCT03508661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03508661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Scleroderma Patient-centered Intervention Network (SPIN) - Scleroderma Support Group Leader EDucation (SSLED) Program Feasibility Trial
Lead sponsor
Lady Davis Institute
Phase
Not applicable
Overall status
Completed
Start date
April 18, 2018
Completion date
August 10, 2018
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma, systemic sclerosis